Literature DB >> 22921887

Effects of supplementation on food intake, body weight and hepatic metabolites in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse model of human citrin deficiency.

Takeyori Saheki1, Kanako Inoue, Hiromi Ono, Natsumi Katsura, Mana Yokogawa, Yukari Yoshidumi, Sumie Furuie, Eishi Kuroda, Miharu Ushikai, Akihiro Asakawa, Akio Inui, Kazuhiro Eto, Takashi Kadowaki, David S Sinasac, Ken-Ichi Yamamura, Keiko Kobayashi.   

Abstract

The C57BL/6:Slc23a13(-/-);Gpd2(-/-) double-knockout (a.k.a., citrin/mitochondrial glycerol 3-phosphate dehydrogenase double knockout or Ctrn/mGPD-KO) mouse displays phenotypic attributes of both neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2), making it a suitable model of human citrin deficiency. In the present study, we show that when mature Ctrn/mGPD-KO mice are switched from a standard chow diet (CE-2) to a purified maintenance diet (AIN-93M), this resulted in a significant loss of body weight as a result of reduced food intake compared to littermate mGPD-KO mice. However, supplementation of the purified maintenance diet with additional protein (from 14% to 22%; and concomitant reduction or corn starch), or with specific supplementation with alanine, sodium glutamate, sodium pyruvate or medium-chain triglycerides (MCT), led to increased food intake and body weight gain near or back to that on chow diet. No such effect was observed when supplementing the diet with other sources of fat that contain long-chain fatty acids. Furthermore, when these supplements were added to a sucrose solution administered enterally to the mice, which has been shown previously to lead to elevated blood ammonia as well as altered hepatic metabolite levels in Ctrn/mGPP-KO mice, this led to metabolic correction. The elevated hepatic glycerol 3-phosphate and citrulline levels after sucrose administration were suppressed by the administration of sodium pyruvate, alanine, sodium glutamate and MCT, although the effect of MCT was relatively small. Low hepatic citrate and increased lysine levels were only found to be corrected by sodium pyruvate, while alanine and sodium glutamate both corrected hepatic glutamate and aspartate levels. Overall, these results suggest that dietary factors including increased protein content, supplementation of specific amino acids like alanine and sodium glutamate, as well as sodium pyruvate and MCT all show beneficial effects on citrin deficiency by increasing the carbohydrate tolerance of Ctrn/mGPD-KO mice, as observed through increased food intake and maintenance of body weight.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22921887     DOI: 10.1016/j.ymgme.2012.07.021

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  6 in total

1.  LAMP5 Fine-Tunes GABAergic Synaptic Transmission in Defined Circuits of the Mouse Brain.

Authors:  Marie-Catherine Tiveron; Corinne Beurrier; Claire Céni; Naly Andriambao; Alexis Combes; Muriel Koehl; Nicolas Maurice; Evelina Gatti; Dhoher Nora Abrous; Lydia Kerkerian-Le Goff; Philippe Pierre; Harold Cremer
Journal:  PLoS One       Date:  2016-06-07       Impact factor: 3.240

2.  Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia.

Authors:  Kiyoshi Hayasaka; Chikahiko Numakura; Kentaro Toyota; Satoru Kakizaki; Hisayoshi Watanabe; Hiroaki Haga; Hiroshi Takahashi; Yoshimi Takahashi; Mieko Kaneko; Mitsunori Yamakawa; Hiroyuki Nunoi; Takeo Kato; Yoshiyuki Ueno; Masatomo Mori
Journal:  Mol Genet Metab Rep       Date:  2014-01-14

Review 3.  AGC2 (Citrin) Deficiency-From Recognition of the Disease till Construction of Therapeutic Procedures.

Authors:  Takeyori Saheki; Mitsuaki Moriyama; Aki Funahashi; Eishi Kuroda
Journal:  Biomolecules       Date:  2020-07-24

4.  Mitochondrial FAD-linked Glycerol-3-phosphate Dehydrogenase: A Target for Cancer Therapeutics.

Authors:  Gurmit Singh
Journal:  Pharmaceuticals (Basel)       Date:  2014-02-11

5.  Inspissated bile syndrome in an infant with citrin deficiency and congenital anomalies of the biliary tract and esophagus: identification and pathogenicity analysis of a novel SLC25A13 mutation with incomplete penetrance.

Authors:  Han-Shi Zeng; Shu-Tao Zhao; Mei Deng; Zhan-Hui Zhang; Xiang-Ran Cai; Feng-Ping Chen; Yuan-Zong Song
Journal:  Int J Mol Med       Date:  2014-09-10       Impact factor: 4.101

6.  Encephalopathy mimicking non-convulsive status Epilepticus.

Authors:  Ramachandiran Nandhagopal; Fathiya Al-Murshedi; Mujahid Al-Busaidi; Amna Al-Busaidi
Journal:  Neurosciences (Riyadh)       Date:  2018-01       Impact factor: 0.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.